What's in S&D Pharma SK s.r.o.'s pipeline?

S&D Pharma SK s.r.o. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with S&D Pharma SK s.r.o.'s portfolio?

Top competitors by shared drug class: BioBalance Corporation, Biocodex, CD Pharma India Pvt. Ltd., CHU de Quebec-Universite Laval, Chuncheon Sacred Heart Hospital.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/s-d-pharma-sk-s-r-o.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

S&D Pharma SK s.r.o. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

S&D Pharma SK s.r.o. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Probio-Tec® BG-VCap-6.5	Probio-Tec® BG-VCap-6.5	phase 3	Probiotic		Gastrointestinal

Therapeutic area mix

Gastrointestinal · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

BioBalance Corporation · 1 shared drug class
Biocodex · 1 shared drug class
CD Pharma India Pvt. Ltd. · 1 shared drug class
CHU de Quebec-Universite Laval · 1 shared drug class
Chuncheon Sacred Heart Hospital · 1 shared drug class
Dow University of Health Sciences · 1 shared drug class
Federico II University · 1 shared drug class
Aga Khan University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for S&D Pharma SK s.r.o.:

Cite this brief

Drug Landscape (2026). S&D Pharma SK s.r.o. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/s-d-pharma-sk-s-r-o. Accessed 2026-05-16.